This Prospectus Supplement supplements the Prospectus dated August 5, 2025 (the “Prospectus”), which forms a part of theRegistration Statement on Form S-1 (File No. 333-286041) (the “Registration Statement”) filed by Lionsgate Studios Corp. (“NewLionsgate”) with the Securities and Exchange Commission (the “SEC”). The Prospectus and this prospectus supplement relate to theexercise from time to time of stock options and stock appreciation rights (“SARs”) outstanding under the Lionsgate Studios Corp. 2025Performance Incentive Plan (the “Plan”), to acquire up to 208,122 common shares of New Lionsgate (the “Common Shares”) that are heldby former employees of Lions Gate Entertainment Corp. and its subsidiaries (including New Lionsgate), who are not current employees orconsultants of New Lionsgate or Starz Entertainment Corp., and any such individuals’ donees, pledgees, permitted transferees, assignees,successors and others who come to hold any such equity award. Any proceeds received by New Lionsgate from the exercise of stockoptions and SARs covered by the Plan (and issued pursuant to the offering described in the Prospectus and this Prospectus Supplement)will be used for general corporate purposes This Prospectus Supplement is being filed to update and supplement the information in the Prospectus with the informationcontained in New Lionsgate’s Current Report on Form 8-K filed with the SEC on April 15, 2026 (the “Form 8-K”). Accordingly, we haveattached a copy of the Form 8-K to this Prospectus Supplement. This Prospectus Supplement updates and supplements the information in the Prospectus and is not complete without, and may not bedelivered or utilized except in combination with, the Prospectus, including any amendments or supplements thereto. This ProspectusSupplement should be read in conjunction with the Prospectus and if there is any inconsistency between the information in the Prospectusand this Prospectus Supplement, you should rely on the information in this Prospectus Supplement. The Common Shares are traded on the New York Stock Exchange (“NYSE”) under the symbol “LION.” On April 14, 2026, the lastreported sale price of the Common Shares was $11.09 per share. See the section entitled “Risk Factors” beginning on page 20 of the Prospectus as well as risks anduncertainties described under similar headings in any amendments or supplements to the Prospectus to readabout factors you should consider before buying securities of New Lionsgate. Neither the SEC nor any state securities commission has approved or disapproved of these securities or passed upon theaccuracy or adequacy of this Prospectus Supplement or the Prospectus. Any representation to the contrary is a criminal offense. The date of this Prospectus Supplement is April 15, 2026 Date of Report (Date of earliest event reported):April13, 2026 Lionsgate Studios Corp. (Exact name of registrant as specified in charter) British Columbia, Canada(State or Other Jurisdiction of Incorporation) N/A (IRS Employer Identification No.) (Address of principal executive offices)250 Howe Street, 20th FloorVancouver, British Columbia V6C 3R8and2700 Colorado AvenueSanta Monica, California 90404 Registrant’s telephone number, including area code:(877)848-3866 No Change(Former name or former address, if changed since last report) Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrantunder any of the following provisions: ☐Written Communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)☐Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)☐Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))☐Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) Securities registered pursuant to Section 12(b) of the Act: Indicate by check mark whether the registrant is an emerging growth company as defined in as defined in Rule 405 of the Securities Actof 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter). Emerging growth company☐ If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period forcomplying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.☐ (e)Compensatory Arrangements of Certain Officers. On April 13, 2026, the Compensation Committee (the “Committee”) of the Board of Directors of Lionsgate Studios Corp. (the“Company”) approved amendments to the Company’s employment agreement with Jon Feltheimer, the Company’s Chief ExecutiveOfficer (the “Agreement’), as set forth in the First Amendment to Employment Agreement, attached hereto as Exhibit 10.1 (the“Amendment”).The Amendment provides that the term of the Agreement will be extended by two years




